Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cidara Therapeutics, Inc. (CDTX) had Receiveable Turnover of 3.93 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$63.91M |
|
$-22.93M |
|
$1.52M |
|
$62.38M |
|
$88.39M |
|
$-24.48M |
|
$2.00M |
|
$-22.49M |
|
$-22.49M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-22.93M |
|
$-24.48M |
|
$-24.29M |
|
4.37M |
|
4.37M |
|
$-5.20 |
|
$-5.20 |
|
| Balance Sheet Financials | |
$60.85M |
|
$0.56M |
|
$6.17M |
|
$67.03M |
|
$67.42M |
|
-- |
|
$7.82M |
|
$75.24M |
|
$-8.21M |
|
$-8.21M |
|
$-8.21M |
|
4.53M |
|
| Cash Flow Statement Financials | |
$-22.43M |
|
$-0.51M |
|
$25.98M |
|
$32.73M |
|
$35.78M |
|
$3.05M |
|
$3.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.90 |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
97.62% |
|
-38.31% |
|
-38.31% |
|
-38.01% |
|
-35.19% |
|
-35.88% |
|
$-22.94M |
|
-- |
|
-- |
|
-- |
|
0.95 |
|
0.25 |
|
|
Receiveable Turnover |
3.93 |
92.79 |
|
279.31% |
|
279.31% |
|
-34.21% |
|
279.31% |
|
$-1.81 |
|
$-5.25 |
|
$-5.13 |
|